Rocket Lab’s Strategic Pivot Collides With SpaceX IPO Jitters

Rocket Lab's shares fell nearly 20% amid SpaceX IPO hype, but the company strengthens its space systems via Motiv acquisition and reports strong Q1 revenue of $200.3M.

Rocket Lab has lost nearly a fifth of its market value in a week, but the sell-off has little to do with its own operations. The culprit is an event that remains weeks away: the long-anticipated initial public offering of SpaceX, which is forcing investors to reassess the entire space sector. The stock closed Friday at $113.42, down 5.45% on the day and well below the 52-week high of $151.00 touched as recently as May 27.

Yet even as the share price slides, the company is quietly strengthening its industrial base. Rocket Lab announced the acquisition of Motiv Space Systems, a specialist in robotic arms and propulsion technology whose hardware has flown on NASA missions to Mars. The deal fits a broader strategy: rather than remain a pure launch provider, Rocket Lab is building out its Space Systems division to own more of the value chain. Past purchases of Geost and Mynaric followed the same logic, and the Motiv addition deepens the company’s capabilities in satellite components and orbital infrastructure.

The SpaceX IPO is a double-edged sword. Expectations for a blockbuster debut — Reuters reports a potential valuation as high as $1.75 trillion, with the listing set for June 12 and an IPO price of $135 — have ignited enthusiasm across the space sector. Stifel analysts raised their Rocket Lab price target to $132, citing operational scale and the attractive margins of HASTE missions. The stock gained 4.6% on Thursday to $119.95 as the SpaceX narrative lifted sentiment. But the subsequent reversal hints at a classic buy-the-rumor, sell-the-news pattern taking hold well before any actual trading begins.

Operationally, Rocket Lab remains in solid shape. First-quarter 2026 revenue came in at $200.3 million, a 63.5% year-over-year jump, while the order backlog stood at $2.2 billion. During the quarter the company signed 31 new Electron and HASTE contracts along with five dedicated Neutron launches, pushing the total booked mission manifest above 70. The next mission, “The Grain Goddess Provides” for Japanese client iQPS, will carry the QPS-SAR-13 satellite into a 575-kilometer orbit from New Zealand, potentially as early as June. That would mark the eighth launch in a planned 15-mission program with iQPS.

The bigger question mark remains the Neutron rocket. After a structural test failure in January, Rocket Lab pushed the first flight to late 2026. Success would open up heavier payload markets and narrow the gap with SpaceX, but any further delay could test investor patience. The annualized 30-day volatility of 135.63% underscores how sharply the stock can swing on such uncertainties.

Adding to the long-term narrative, Rocket Lab in February unveiled advanced solar cells designed to power gigawatt-scale data centers in orbit — a technology that reduces reliance on gallium arsenide and germanium supply chains. The move aligns with the AI-infrastructure story that SpaceX is also leaning into for its IPO, making orbital computing capacity a direct comparison point for investors.

Technically, the correction has cooled an overheated stock. The relative strength index now sits at 51.9, neutral territory, and at $113.42 the shares still trade well above the 50-day moving average of $96.20 and the 200-day average of $72.64. Year-to-date the stock remains up roughly 50%, and over the past twelve months the gain is approximately 329%. But with the sector’s benchmark now in play, Rocket Lab must convert its $2.2 billion backlog and Neutron development into concrete financial results — before SpaceX resets the yardstick for the entire industry.